Cantourage Group SE
HIGH
Company Profile
Business description
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
Contact
Feurigstrasse 54
Berlin10827
DEUT: +49 304701350
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
7
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,874.20 | 25.80 | 0.29% |
| CAC 40 | 8,095.58 | 10.58 | -0.13% |
| DAX 40 | 24,074.25 | 2.62 | -0.01% |
| Dow JONES (US) | 48,262.16 | 147.90 | 0.31% |
| FTSE 100 | 9,838.60 | 153.81 | 1.59% |
| HKSE | 25,468.78 | 233.37 | 0.92% |
| NASDAQ | 23,079.47 | 32.00 | -0.14% |
| Nikkei 225 | 49,512.28 | 128.99 | 0.26% |
| NZX 50 Index | 13,295.91 | 129.04 | -0.96% |
| S&P 500 | 6,798.20 | 2.06 | -0.03% |
| S&P/ASX 200 | 8,585.20 | 21.60 | 0.25% |
| SSE Composite Index | 3,870.28 | 45.47 | 1.19% |